We’re thrilled to announce that Jouni Heikkinen, Key Account Manager, and Janne Ylärinne, Sales Director, will be representing Biosafe at The Future of Protein Production 2024, taking place on October 23-24, 2024, at the RAI Amsterdam. This pivotal event, held concurrently with the Regulating the Future of Foods conference, will bring together innovators, industry leaders, and stakeholders to explore the latest advancements in the alternative protein sector.
The Summit
The Future of Protein Production 2024 conference is designed to address the complex challenges surrounding the development and adoption of alternative proteins. As the global demand for sustainable and ethical protein sources grows, this event serves as a platform for stakeholders across the industry—ranging from innovators and food producers to investors and government agencies—to come together and collaborate. The goal is to make alternative proteins more accessible, affordable, and delicious, while advancing technologies that enhance taste, texture, and scalability. This conference will explore the latest industry trends, tackle the technological and regulatory barriers, and share insights on how alternative proteins can meet the demands of a growing global population, benefiting both human health and the environment. With a strong focus on sustainability, nutrition, and efficiency, this event will provide participants with the knowledge and connections needed to drive the future of protein production.
Biosafe at The Future of Protein Production
Biosafe is committed to helping companies navigate the regulatory pathways needed to bring novel proteins and alternative protein products to market safely and efficiently. As leaders in food safety and regulatory affairs, we see The Future of Protein Production 2024 as an invaluable platform for staying at the forefront of protein innovation and regulatory developments. We’re especially keen to learn from our clients who are presenting and leading discussions at this summit, further driving progress in the industry.
Key Sessions Biosafe is Looking Forward To
Some of the notable sessions at the summit in our opinion are:
1. Panel Discussion: State of the Industry – Navigating Challenges and Opportunities
October 23, 10:30 – 11:00 AM
This panel addresses the major hurdles faced by the alternative protein industry, such as navigating regulatory frameworks, consumer skepticism, and fundraising challenges. For Biosafe, which works closely with clients to ensure regulatory compliance and smooth market entry, understanding these challenges is key to helping clients overcome barriers. The panel also covers important topics like cultivated meat controversies, EU policy changes, and strategies to build public trust through effective communication.
Panelists:
- Clement Tischer, Head of FoodTech, REWE Group
- Jens Tuider, Chief Strategy Officer, ProVeg International
- Urbi Pathak, Research Associate, Lux Research
2. Regulatory State of the Nation in the EU
October 24, 9:30 – 9:50 AM
The EU’s strict food safety standards and the challenges associated with novel foods and GMO regulations make this session a must-attend for Biosafe and its clients. The session will explore the latest regulatory developments in the EU, including updated EFSA Novel Food Guidance and the Hygiene Regulation for cultivated meat. Understanding these changes is crucial for clients looking to accelerate their novel protein applications and gain entry into the lucrative EU market.
Speaker:
- Karin Verzijden, Life Sciences Lawyer, Partner, AXON Lawyers
3. How to Engage with EFSA to Speed the Regulatory Application Process
October 24, 9:50 – 10:10 AM
This session will provide practical strategies for working with EFSA to streamline the approval process for novel proteins. For Biosafe, which specializes in helping clients navigate EFSA’s complex evaluation criteria, this session offers insights into optimizing regulatory engagement, compiling strong dossiers, and avoiding common pitfalls that delay market entry. These strategies are essential for clients aiming to reduce time-to-market for their innovative food products.
Speaker:
- Wolfgang Gelbmann, Senior Scientific Officer, European Food Safety Authority (EFSA)
4. Global Regulatory Insights: Solar Foods' Experience in Various Markets
October 24, 10:10 – 10:30 AM
This presentation will offer an in-depth look at the regulatory journey of Solar Foods, a Finnish biotech startup navigating the regulatory landscapes of Singapore, the EU, and the UK. The session will highlight the challenges and lessons learned from entering these diverse markets, offering valuable strategic insights into adapting to different regulatory environments. Biosafe’s clients operating globally will find this session particularly relevant for understanding how to manage regulatory complexities across multiple regions.
Speaker:
- Ida Søndergaard, Regulatory Affairs Manager, Solar Foods
5. Panel Discussion: Ensuring Food Safety in Novel Proteins – Navigating Regulatory Innovation
October 24, 10:30 – 11:00 AM
As food safety becomes a critical concern in the novel proteins sector, this panel will explore the regulatory innovations needed to ensure safe commercialization of these new protein sources. For Biosafe and its clients, staying informed about safety testing standards and regulatory frameworks is key to ensuring compliance and mitigating risks. This discussion will provide insights into standardizing safety assessments and overcoming regulatory challenges to ensure smooth approval processes for novel proteins.
Panelists:
- Kimberly Ong, Safety and Regulatory Consultant, Vireo Advisors
- Olivia de Talance, COO, Vital Meat
- Thomas Horgan, Senior Policy Adviser, Food Standards Agency (FSA)
- Mathilde Do Chi, Managing Director, Forward Food Law
- André Silva, Segment Marketing Specialist WEU, Merck
Meet Biosafe at The Future of Protein Production 2024
Jouni Heikkinen and Janne Ylärinne will be attending the event and are eager to connect with attendees who want to learn more about how Biosafe can support their regulatory compliance, product safety, and market access needs in the alternative protein sector. Whether you're looking to understand how to navigate EU and US regulatory frameworks or need expert insights on how to bring novel proteins to market safely, our team is here to help.
We encourage you to book a meeting with Jouni and Janne via our meeting booking link to discuss how Biosafe can assist your company in this rapidly evolving industry.
Meet us on 23–24 October in Amsterdam!
|
Jouni Heikkinen, PhD
|
|
Janne Ylärinne, PhD
|
